Trial intelligence / Profile preview

Comparison of Conservative Treatments in Carpal Tunnel Syndrome

NCT05475808Phase 4Active, not recruiting

Sponsor
Bolu Abant Izzet Baysal University
Start
Aug 2022
Primary completion
Jul 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of betamethasone dipropionate + betamethasone sodium phosphate in carpal tunnel syndrome (CTS), sponsored by Bolu Abant Izzet Baysal University. Started Aug 2022; status: active, not recruiting.

02

Drugs

betamethasone dipropionate + betamethasone sodium phosphate
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT05475808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05475808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call